Exploring the Endocannabinoid System and Child Development
The endocannabinoid system and child development are closely studied in relation to maternal cannabis use. Prenatal cannabis exposure may influence behavioral and developmental outcomes in children. These effects vary depending on the presence of autism…
Clinical Insights on GLP-1 Receptor Agonists and Mental Health
This guide reviews the glp-1 receptor agonists mental health evidence, highlighting current research on their effects on major mental illnesses. While some mood improvements are noted, these medications are not primary psychiatric treatments.…
Cannabidiol Effects on Autism Anxiety and Social Behavior
This cannabidiol autism anxiety clinical trial evaluated CBD oil's effects on social interaction and anxiety symptoms in autistic children. The study found measurable improvements in social relating and reduced anxiety. These findings highlight CBD's…
Endocannabinoid System Research: Clinical Evidence Review
This review highlights key endocannabinoid system clinical research findings relevant to personalized cannabis prevention. Tailored messaging addressing adolescent objections improves engagement. These findings support more effective substance abuse…
Endocannabinoid System Clinical Research on Psychosis Risk
Patients with cannabis induced psychosis schizophrenia risk have a documented chance of developing schizophrenia spectrum or bipolar disorder. Clinical research highlights the importance of early identification and monitoring. Understanding this risk…
Cannabinoid Clinical Trials: Anxiety and Tourette Syndrome Insights
This article reviews the effects of cannabinoid formulations on anxiety disorders and Tourette syndrome. Clinical trials show varied outcomes with CBD and THC compounds. Understanding these effects is crucial for individualized treatment decisions.
Endocannabinoid System and Cannabis Dosing: Clinical Research
This article reviews endocannabinoid system cannabis dosing research and its clinical implications. Understanding cannabis dosing is essential for optimizing therapeutic outcomes. Clinical research highlights the role of the endocannabinoid system in…
Understanding Cannabidiol Supplement Use and Doping Risk
Cannabidiol supplement doping risk is a critical concern for athletes using broad-spectrum CBD products. These supplements can cause accumulation of prohibited cannabinoids detectable in urine. Exercise further amplifies this risk, increasing chances of…
Cannabidiol Clinical Trials: High Risk Psychosis Research
Cannabidiol clinical trials reveal how a single dose of CBD affects hippocampal glutamate and brain activation in high risk psychosis. These trials suggest CBD's potential to normalize brain chemistry in early psychosis. Ongoing research aims to confirm…
Topical Cannabis for AIMSS: Clinical Trial Evidence
Aromatase inhibitor joint pain relief cannabis balms were tolerable and feasible for women with AIMSS. This approach may improve adherence to breast cancer medications by reducing joint pain and stiffness. Preliminary clinical trial evidence supports…